Shidlovski/iStock via Getty Images
- AbbVie (NYSE:ABBV) said on Tuesday that the European Commission approved the marketing authorization of Rinvoq for the treatment of giant cell arteritis.
- The approval is backed by positive data from a late-stage trial where Rinvoq met the main goal of